Katharine Saussy, MD
Dermatology · New Orleans, LANPI 1285175513
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 97.0% of the total across 241 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 28 manufacturers reported payments, led by AbbVie at 28.2% of the total.
Across 241 payments — averaging $26.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Sanofi$592
- Pfizer$500
- Amgen$401
- Regeneron Healthcare Solutions, Inc.$400
- Incyte Corporation$291
- plus $2K from 22 others
What the payments were for
- Food & beverage$6,15397%
- Education$1873%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 71 | $1,786 |
| Sanofi | 23 | $592 |
| Pfizer | 16 | $500 |
| Amgen | 14 | $401 |
| Regeneron Healthcare Solutions, Inc. | 14 | $400 |
| Incyte Corporation | 9 | $291 |
| Journey Medical Corporation | 4 | $289 |
| E.r. Squibb & Sons, L.L.C. | 16 | $280 |
| Johnson & Johnson | 9 | $255 |
| Lilly USA, LLC | 10 | $231 |
| UCB, Inc. | 10 | $224 |
| Merz North America, Inc. | 2 | $171 |
| Dermavant Sciences, Inc. | 7 | $131 |
| Sun Pharmaceutical Industries Inc. | 6 | $121 |
| Novartis | 5 | $110 |
| Mayne Pharma Commercial LLC | 4 | $96 |
| Sanofi-aventis U.S. LLC | 1 | $80 |
| Galderma Laboratories, L.p. | 4 | $60 |
| Arcutis Biotherapeutics, Inc. | 3 | $56 |
| Boehringer Ingelheim | 2 | $50 |
| Almirall LLC | 2 | $47 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 2 | $42 |
| Helsinn Therapeutics (U.S.), Inc. | 2 | $37 |
| LEO Pharma Inc. | 1 | $26 |
| Solta Medical, A Division Of Bausch Health US, LLC | 1 | $24 |
| Genentech USA, Inc. | 1 | $19 |
| Botanix SB Inc | 1 | $19 |
| Organon | 1 | $5 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,341 in reported general payments places this provider in the 55th percentile of 189 dermatology providers in Louisiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clobetasol Propionate | 33 | $1,056 |
| Tacrolimus | 12 | $770 |
| Ketoconazole | 46 | $680 |
| Triamcinolone Acetonide | 40 | $397 |
| Mupirocin | 22 | $124 |
| Hydrocortisone | 11 | $65 |
| Finasteride | 14 | $48 |
Paid to pharmacies, not to this prescriber.
Other dermatology in New Orleans
- William ClaiborneNew Orleans$374K
- Erin BohNew Orleans$277K
- Mara HaseltineNew Orleans$276K
- Julie MermilliodNew Orleans$222K
- Sarah JacksonNew Orleans$167K
- Deirdre HooperNew Orleans$144K
- Patricia HickhamNew Orleans$12K
- Stephen KlingerNew Orleans$11K
- Katherine HolcombMetairie$411K
- Blair BuddenLafayette$329K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.